Baird Financial Group Inc. Grows Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Baird Financial Group Inc. grew its position in Surgery Partners, Inc. (NASDAQ:SGRYGet Rating) by 35.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,751 shares of the company’s stock after purchasing an additional 2,825 shares during the period. Baird Financial Group Inc.’s holdings in Surgery Partners were worth $311,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Cannell & Co. lifted its position in Surgery Partners by 59.9% during the second quarter. Cannell & Co. now owns 361,245 shares of the company’s stock valued at $10,447,000 after buying an additional 135,270 shares in the last quarter. Level Four Advisory Services LLC acquired a new position in shares of Surgery Partners during the 2nd quarter valued at $584,000. Envestnet Asset Management Inc. lifted its holdings in shares of Surgery Partners by 11.0% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,113 shares of the company’s stock valued at $379,000 after acquiring an additional 1,298 shares in the last quarter. Wolverine Asset Management LLC boosted its position in Surgery Partners by 2.5% during the 2nd quarter. Wolverine Asset Management LLC now owns 16,541 shares of the company’s stock worth $478,000 after purchasing an additional 400 shares during the period. Finally, SG Americas Securities LLC purchased a new position in Surgery Partners in the second quarter valued at about $108,000.

Surgery Partners Trading Up 2.3 %

NASDAQ SGRY opened at $25.74 on Wednesday. The company has a market capitalization of $2.32 billion, a price-to-earnings ratio of -73.54 and a beta of 2.82. The company has a debt-to-equity ratio of 1.47, a current ratio of 1.18 and a quick ratio of 1.07. Surgery Partners, Inc. has a 12 month low of $20.46 and a 12 month high of $63.87. The company’s fifty day moving average price is $26.10 and its two-hundred day moving average price is $31.67.

Insider Transactions at Surgery Partners

In related news, Director Brent Turner purchased 10,000 shares of Surgery Partners stock in a transaction dated Monday, November 21st. The shares were acquired at an average price of $24.50 per share, with a total value of $245,000.00. Following the completion of the transaction, the director now owns 57,701 shares of the company’s stock, valued at approximately $1,413,674.50. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Laura L. Brocklehurst sold 4,338 shares of the business’s stock in a transaction that occurred on Wednesday, November 9th. The stock was sold at an average price of $22.96, for a total value of $99,600.48. Following the completion of the sale, the insider now directly owns 41,424 shares in the company, valued at approximately $951,095.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Brent Turner purchased 10,000 shares of the company’s stock in a transaction that occurred on Monday, November 21st. The shares were purchased at an average cost of $24.50 per share, for a total transaction of $245,000.00. Following the completion of the transaction, the director now owns 57,701 shares in the company, valued at approximately $1,413,674.50. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 4,671 shares of company stock valued at $109,474. Insiders own 3.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on SGRY. StockNews.com downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research report on Saturday, November 5th. Cowen lowered their price objective on shares of Surgery Partners to $35.00 in a research report on Wednesday, November 16th. Royal Bank of Canada reduced their target price on shares of Surgery Partners from $62.00 to $58.00 and set an “outperform” rating on the stock in a research report on Thursday, November 10th. Stifel Nicolaus lowered their price target on shares of Surgery Partners from $44.00 to $36.00 in a report on Tuesday. Finally, Citigroup cut their price objective on shares of Surgery Partners from $49.00 to $38.00 and set a “buy” rating on the stock in a report on Wednesday, November 9th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average price target of $49.22.

About Surgery Partners

(Get Rating)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.